• Explore /
  • Poster
  • / A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC).

A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC).

Abstract Poster

Authors

null

Irbaz Bin Riaz

Mayo Clinic, Rochester, MN

Irbaz Bin Riaz , Huan He , Alexander J. Ryu , Rabbia Siddiqi , Syed Arsalan Ahmed Naqvi , Yuan Yao , Muhammad Husnain , Deepa Maheswari , Qurat Ul Ain Riaz Sipra , Victor Montori , Richard Wayne Joseph , Hongfang Liu , Zhen Wang , Vitaly Herasevich , Parminder Singh , Thai Huu Ho , Alan Haruo Bryce , Lance C. Pagliaro , M. Hassan Murad , Brian Addis Costello

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 335)

DOI

10.1200/JCO.2021.39.6_suppl.335

Abstract #

335

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Garima Gupta

Poster

2020 Genitourinary Cancers Symposium

A systematic review and network meta-analysis of first-line treatment options in patients metastatic renal cell carcinoma.

A systematic review and network meta-analysis of first-line treatment options in patients metastatic renal cell carcinoma.

First Author: Irbaz Bin Riaz

First Author: Aung Tun

First Author: Connor Wells